Suggest One No specific molecular structure known for this excipient.
UNII
HHT01ZNK31
CAS
151687-96-6
SYNONYMS
  • Carbopol 974
  • Carbomer Homopolymer Type B (allyl Pentaerythritol Crosslinked)
  • Carbomer 974
  • Carbomer Homopolymer Type B (allyl Pentaerythritol Crosslinked) [ii]
  • Carbomer 974 [ii]
  • Carbomer Homopolymer (allyl Pentaerythritol Crosslinked; 35000 Mpa.s)
  • Carbomer Homopolymer (allyl Pentaerythritol Crosslinked; 25000-45000 Mpa.s)
  • Carbomer 934p (allyl Pentaerythritol Crosslinked)
  • Carbomer 974 (p)
  • Carbomer 974p
  • Carbopol 974p
  • K61870z308
  • Carbomer-974p
  • Acrylic Acid Cross-Linked With Allyl Ethers Of Polyalcohols (viscosity 25000 To 45000 Mpa.s)
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Analogs cannot be located as there is no structure provided for this compound. Try a search by name.

Dosages

Route Formulation Per Unit Dose
Ophthalmic Gel 0.48%
Ophthalmic Suspension 0.5%
Ophthalmic Suspension, Drops 0.45%
Topical Gel 1.25%
Topical Suspension 0.4%
Oral Granule, For Suspension 150MG
Oral Suspension 0.16%
Oral Tablet, Extended Release 6.25MG

More Information

Usage Over Time

Comments